Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $4.36 million. The enterprise value is -$7.28 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 2.00 million shares outstanding. The number of shares has increased by 1,293.12% in one year.
| Current Share Class | 2.00M |
| Shares Outstanding | 2.00M |
| Shares Change (YoY) | +1,293.12% |
| Shares Change (QoQ) | +2,449.10% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 1.98% |
| Float | 2.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| Forward PS | 0.28 |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.74, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.74 |
| Quick Ratio | 3.41 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -163.45 |
Financial Efficiency
Return on equity (ROE) is -17.98% and return on invested capital (ROIC) is -12.86%.
| Return on Equity (ROE) | -17.98% |
| Return on Assets (ROA) | -10.75% |
| Return on Capital (ROIC) | -12.86% |
| Revenue Per Employee | $749,079 |
| Profits Per Employee | -$96,044 |
| Employee Count | 44 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 3.18 |
Taxes
In the past 12 months, SBFM has paid $114,146 in taxes.
| Income Tax | 114,146 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.59% in the last 52 weeks. The beta is -1.04, so SBFM's price volatility has been lower than the market average.
| Beta (5Y) | -1.04 |
| 52-Week Price Change | -99.59% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 44.35 |
| Relative Strength Index (RSI) | 21.48 |
| Average Volume (20 Days) | 143,127 |
Short Selling Information
The latest short interest is 374,131, so 18.71% of the outstanding shares have been sold short.
| Short Interest | 374,131 |
| Short Previous Month | 321,526 |
| Short % of Shares Out | 18.71% |
| Short % of Float | 18.73% |
| Short Ratio (days to cover) | 4.13 |
Income Statement
In the last 12 months, SBFM had revenue of $32.96 million and -$4.23 million in losses. Loss per share was -$26.01.
| Revenue | 32.96M |
| Gross Profit | 10.14M |
| Operating Income | -4.96M |
| Pretax Income | -3.72M |
| Net Income | -4.23M |
| EBITDA | -4.76M |
| EBIT | -4.96M |
| Loss Per Share | -$26.01 |
Full Income StatementBalance Sheet
The company has $12.21 million in cash and $556,551 in debt, giving a net cash position of $11.65 million or $5.83 per share.
| Cash & Cash Equivalents | 12.21M |
| Total Debt | 556,551 |
| Net Cash | 11.65M |
| Net Cash Per Share | $5.83 |
| Equity (Book Value) | 25.04M |
| Book Value Per Share | 12.52 |
| Working Capital | 21.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.81 million and capital expenditures -$1.17 million, giving a free cash flow of -$12.99 million.
| Operating Cash Flow | -11.81M |
| Capital Expenditures | -1.17M |
| Free Cash Flow | -12.99M |
| FCF Per Share | -$6.49 |
Full Cash Flow StatementMargins
Gross margin is 30.78%, with operating and profit margins of -15.05% and -12.82%.
| Gross Margin | 30.78% |
| Operating Margin | -15.05% |
| Pretax Margin | -12.48% |
| Profit Margin | -12.82% |
| EBITDA Margin | -14.45% |
| EBIT Margin | -15.05% |
| FCF Margin | -37.87% |